|
|
BULLETIN
IOM Names Five Faculty Members from HMS and HSPH
Four HMS and one HSPH faculty members were among the 65 new
members elected to the Institute of Medicine for 2007. The
IOM, part of the National Academy of Sciences, is an advisory
group that provides information and analysis to national policymakers
on issues pertaining to health, biomedical science, and medicine.
Emery Brown
Massachusetts General Hospital Professor of Anesthesia,
MGH
In his statistical research, Brown develops signal processing
algorithms and statistical methods to study how the brain and
nervous system represent and transmit information. His experimental
research uses combined functional magnetic resonance imaging
and electroencephalogram recordings to study how anesthetic
drugs induce the state of general anesthesia in the brain.
William Kaelin
Howard Hughes Investigator, Professor of Medicine,
Dana–Farber Cancer Institute
Kaelin studies tumor suppressor genes and the normal functions
of the proteins they encode, with a focus on the von Hippel–Lindau
tumor suppressor protein, the retinoblastoma tumor suppressor
protein, and the p53-like protein p73. His group is also studying
tuberous sclerosis, a hereditary cancer syndrome caused by
mutations in either of two genes.
David Scadden
Gerald and Darlene Jordan Professor of Medicine, MGH
Scadden’s research focuses on stem cell biology, emphasizing
blood stem cells and the mechanisms by which they are governed.
He has defined molecules affecting stem cell proliferation
and specific components of the complex niche in which they
reside. His research is linked to developing new therapies
for immunocompromised patients with AIDS or cancer, and he
has led related clinical trials.
Jonathan Seidman
Henrietta B. and Frederick H. Bugher Foundation Professor of
Genetics, HMS
Jonathan Seidman works with lab co-director Christine Seidman
to integrate clinical medicine and molecular technologies to
define disease-causing gene mutations and genetic variations
that increase disease risk. Major research projects focus on
discovery of the genetic contributions to cardiomyopathies,
hearing loss, and congenital heart disease.
Katherine Swartz
Professor of Health Economics and Policy, HSPH
Swartz’s research interests focus on the population without
health insurance and efforts to increase access to health care
coverage; reasons for and ways to control episodes of care
that involve extremely high expenditures; and ways to pay for
expanded health insurance coverage. She also is interested
in the impact of mapping the human genome and its implications
for health insurance.
HHMI Selects Four from HMS
The Howard Hughes Medical Institute has appointed four HMS faculty members
as patient-oriented researchers from a competition specifically aimed at physician-scientists
who divide their time between research and patient care. There were only 15
appointments nationwide. The program, which began in 2002, reflects HHMI’s
commitment to ensuring that basic research is translated into treatments.
The four new Howard Hughes investigators are George Daley, Elizabeth Engle,
Daniel Haber, and S. Ananth Karumanchi.
The focus of Daley’s research is the hematopoietic stem cell (HSC), which
gives rise to progenitors of all the differentiated specialized blood cells.
Early in his career, Daley, an HMS associate professor of biological chemistry
and molecular pharmacology at Children’s Hospital Boston, showed that
the oncogene Bcr-Abl, which spurs malignant growth of HSCs and overproliferation
of white blood cells, is responsible for chronic myelogenous leukemia (CML).
Engle, HMS associate professor of neurology at Children’s, identified
a series of congenital disorders that prevent normal control of eye movement.
She found 700 families with these or similar disorders and discovered that
the cause was a genetic mutation preventing normal development of one or more
cranial nerves. She is now studying this developmental problem in mice.
Haber, the Laurel Schwartz professor of medicine at Massachusetts General
Hospital, studies cancer genetics, with a focus on Wilms’ tumor, a cancer of the
kidney that usually occurs in children. Haber characterized a gene that is
mutated in 10 percent of Wilms’ patients and has recently discovered
another mutation found in 30 percent of patients.
Karumanchi, HMS associate professor of medicine at Beth Israel Deaconess
Medical Center, studies preeclampsia, a rare but dangerous condition that affects
the kidneys and blood pressure of women in late-term pregnancy. He discovered
that a protein, sFLT1, is found in unusually high amounts in the placentas
of preeclampsic women and prevents two other proteins that maintain the endothelial
lining of blood vessels from doing their job, resulting in hypertension and
protein leakage. He is currently studying the molecular mechanisms behind preeclampsia
symptoms.
Harvard Medical School recently received accreditation from the
Association for the Accreditation of Human Research Protection Programs.
To receive this accreditation, institutions must demonstrate safeguards
for research participants that go above and beyond the federal and
state requirements. The accreditation is valid for three years.
Hiatt Receives IOM’s Lienhard Award
Howard Hiatt, HMS professor of medicine at Brigham and Women’s
Hospital and former dean of HSPH, has won the Institute of Medicine’s
2007 Gustav O. Lienhard Award, which recognizes individuals for outstanding
achievement in improving health care services in the United States. Hiatt
founded the Harvard Medical Practice Study, a highly regarded investigation
of medical malpractice that has resulted in the publication of two reports,
and he had a key role in the development of the Division of Social Medicine
and Health Inequalities at BWH, which graduated its first two residents
last June. Hiatt has also played a part in the growth of Partners In Health,
which forms relationships with health care providers in poor countries
to lower disease rates, and the Institute for Healthcare Improvement, an
organization that works to accelerate the improvement of health care. The
award includes a medal and $25,000.
Amos Portrait Unveiled at HMS

The Harvard Foundation unveiled a portrait of Harold Amos, the first
African American to chair a department at HMS, in a ceremony on the Quad
on Oct. 4. Amos, the Maude and Lillian Presley professor emeritus of microbiology
and molecular genetics, passed away in 2003 at the age of 84 after a career
at the School that spanned nearly 50 years. In addition to twice chairing
the Department of Microbiology and Molecular Genetics, Amos was a popular
teacher and mentor at both HMS and the Faculty of Arts and Sciences. The
framed, oil-on-canvas portrait, painted by Harvard alumnus Stephen Coit, ’72,
will make its permanent home outside the Armenise Amphitheater. The Amos
portrait is part of the Minority Portraiture Project, started with a $100,000
gift to the Harvard Foundation from then president Lawrence Summers. Pictured
at the ceremony, from left, are Chester Pierce, professor emeritus of
education and psychiatry in the Faculty of Medicine and School of Education;
Coit; and Allen Counter, head of the Harvard Foundation.
Federal Grant Launches Study of Lung Disease
Researchers at Brigham and Women’s Hospital and the National Jewish
Medical and Research Center have been awarded $37 million from the National
Heart, Lung, and Blood Institute to lead a study on chronic obstructive
pulmonary disease (COPD) that will seek to identify its genetic, epidemiological,
and radiological characteristics. COPD, an umbrella term used to describe
several progressive lung disorders such as emphysema and chronic bronchitis,
is the fourth leading cause of death in the U.S. and the only leading
cause that is increasing in frequency. The study will enroll a total of
10,500 participants. Approximately 3,500 of them will be African American
since the rate of disease is increasing rapidly in this population and
the risk factors are not well understood. Edwin Silverman, HMS associate
professor of medicine at BWH, is a co-principal investigator of the study.
HSPH will provide statistical analysis, along with Johns Hopkins University
and the University of Colorado.
Community Service Awards Announced
The Office for Diversity and Community Partnership has honored six HMS
faculty members with a 2007 Dean’s Community Service Award, presented
at a breakfast ceremony on Oct. 25. The awards were initiated in 1999
by then dean Joseph Martin to honor HMS faculty, trainees, students, and
staff for extraordinary contributions to community service and to encourage
volunteering. The 2007 Lifetime Achievement winner is Lachlan Forrow,
HMS associate professor of medicine at Beth Israel Deaconess Medical Center,
for his work with the Albert Schweitzer Fellowship. Rhonda Fogle, an HMS
clinical instructor in pediatrics at Children’s Hospital Boston,
received the faculty award for her service with the Association for Retarded
Citizens of Eastern Middlesex. And Bertram Zarins, the Augustus Thorndike
clinical professor of orthopedic surgery at Massachusetts General Hospital,
received the faculty award for volunteering with the Latvian Medical Foundation.
Ryan Thompson, a clinical fellow in medicine at MGH, won the trainee award
for his work with the MGH Department of Internal Medicine. Elizabeth Cote,
Class of 2008, received the student award for her time dedicated to the
Kalaiselvi Karunalaya Social Welfare Society. The winner of the staff
award is Dave Rizzotto, formerly an HMS media technician specialist, for
volunteering with Newbury Film Series Inc.
Genomics Program Expands At HMS
The National Human Genome Research Institute, part of the National Institutes
of Health, has expanded the Encyclopedia of DNA Elements (ENCODE) project
with funding of more than $80 million over the next four years. The purpose
of the ENCODE project is to search the human genome for DNA that has a
biological function other than coding for protein, identify those functions,
and investigate how they work. The new support will expand the grants
of investigators already working on the project, allow for the development
of two pilot projects, establish an ENCODE data coordination center, and
create six sites that will develop novel methods and technologies for
use in ENCODE projects.
Bradley Bernstein, HMS associate professor of pathology at Massachusetts
General Hospital, is the principal investigator on a component of the
project titled “High-throughput Sequencing of Chromatin Regulatory
Elements,” which was funded at $4.8 million over four years. Utilizing
the technique of chromatin immunoprecipitation followed by high-throughput
DNA sequencing, Bernstein and his colleagues will map modifications of
histones in various types of human cells.
Kidney Stone Research Program Funded by NIH
The National Institutes of Health has awarded an $8.5 million grant
to Gary Curhan, HMS assistant professor of medicine at Brigham and Women’s
Hospital, for a project to increase understanding of the pathophysiology
of kidney stones. The three-part study will explore the physiological
processes, genetic predisposition, and gene–environment interactions
that contribute to risk for kidney stone formation using genomewide association
studies in participants from the Health Professionals Follow-up Study,
the Nurses’ Health Study, and the Nurses’ Health Study II,
and in animal models and transport studies. Other BWH investigators on
the project include David Mount, HMS assistant professor of medicine;
Martin Pollak, HMS associate professor of medicine; Meir Stampfer, HMS
professor of medicine and HSPH professor of nutrition and epidemiology;
and Eric Taylor, HMS instructor in medicine.
top
|